Biotech · Private company
Ventus Therapeutics U.S., Inc.
Track this companyFree. Adds Ventus Therapeutics U.S., Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- VENT-02Phase 2 · Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- VENT-03Phase 2 · Cutaneous Lupus Erythematosus (CLE)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus ErythematosusPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 3, 2025ClinicalTrials.gov NCT07260877 · fetched Nov 12, 2026
- A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's DiseasePHASE1_PHASE2 · TERMINATED · started Mar 5, 2025ClinicalTrials.gov NCT06822517 · fetched Nov 12, 2026